The power of combining adoptive cell therapy (ACT) and pathogen-boosted vaccination to treat solid tumors
Recent advancements in adoptive cell therapy (ACT) are opening up new frontiers for cancer immunotherapy. CAR T cells targeting CD19 have emerged as a remarkable T cell-based therapy for the successful treatment of certain types of leukemia and lymphomas. Despite these clinical successes, as well as...
Main Authors: | Ryan Zander, Weiguo Cui |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-10-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2017.1345833 |
Similar Items
-
Pathogen boosted adoptive cell transfer immunotherapy to treat solid tumors
by: Xin, Gang, et al.
Published: (2017) -
Strategic Forecasting of Vaccine Adoption by GAVI-Eligible Countries
by: Kabiling, Wiko
Published: (2016) -
Registration of Adoptions Act 1952, Adoption Act 1952 : (incorporating all amendments as at 10th June, 1985) /
by: 482513 Malaysia, et al.
Published: (1985) -
Adoption Act, 1952 & Adoption Rules, 1955 (as at 1st September 1985) /
by: 482513 Malaysia, et al.
Published: (1985) -
Understanding the role of exogenous boosting in modeling varicella vaccination
by: Sandra E. Talbird, et al.
Published: (2018-11-01)